Showing results (41-50 of 103) with videos related to
Sort By:
Pageof 11
Blood|May 9, 2001
The basophil activation marker defined by antibody 97A6 is identical to the ectonucleotide pyrophosphatase/phosphodiesterase 3H J Bühring, M Seiffert, C Giesert, et al.Journal of Neurology, Neurosurgery, and Psychiatry|January 1, 1993
Thymectomy and azathioprine have no effect on the phenotype of CD4 T lymphocyte subsets in myasthenia gravisA Melms, G Malcherek, U Gern, et al.Annals of the New York Academy of Sciences|July 19, 2001
The monoclonal antibody W7C5 defines a novel surface antigen on hematopoietic stem cellsC Giesert, G Almeida-Porada, A Scheffold, et al.Immunobiology|August 1, 1987
Stable expression of clonal specificity in murine cytomegalovirus-specific large granular lymphoblast lines propagated long-term in recombinant interleukin 2M J Reddehase, R Zawatzky, F Weiland, et al.Allergy|August 22, 2006
Detection of novel leukocyte differentiation antigens on basophils and mast cells by HLDA8 antibodiesS Florian, K Sonneck, M Czerny, et al.Immunology Letters|August 1, 1993
Expression of an early myelopoietic antigen (CD33) on a subset of human umbilical cord blood-derived natural killer cellsR Handgretinger, H J Schäfer, F Baur, et al.Neuropathology and Applied Neurobiology|November 7, 2006
Upregulation of frizzled 9 in astrocytomasZ Zhang, J Schittenhelm, K Guo, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1990
Susceptibility of autologous target cells to lysis by lymphokine-activated effectors from interferon-alpha-treated chronic myelogenous leukaemia patientsG Pawelec, G Ehninger, H Schmidt, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1991
Clinical trial of natural human lymphocyte-derived interleukin 2 in cancer patients: effects on cytokine production and suppressor cell statusG Pawelec, H J Lenz, E Schneider, et al.European Journal of Immunology|August 15, 2000
Association of signal-regulatory proteins beta with KARAP/DAP-12E Tomasello, C Cant, H J Bühring, et al.Pageof 11